郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

心血管疾病Acute toxicity and genotoxicity evaluations of Nattokinase, a promising agent for cardiovascular diseases prevention.

期刊：Regulatory toxicology and pharmacology : RTP发表年份：2019作者：Hao Wu; Huan Wang; Feng Xu; Jiepeng Chen; Lili Duan; Fengjiao Zhang
阅读更多 →

心血管疾病Pharmacological Characterization of a Novel 5-Hydroxybenzothiazolone-Derived β 2-Adrenoceptor Agonist with Functional Selectivity for Anabolic Effects on Skeletal Muscle Resulting in a Wider Cardiovascular Safety Window in Preclinical Studies.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2019作者：Magdalena Koziczak-Holbro; Dean F Rigel; Bérengère Dumotier; David A Sykes; Jeffrey Tsao; Ngoc-Hong Nguyen; Julian Bösch; Marie Jourdain; Ludivine Flotte; Yuichiro Adachi; Michael Kiffe; Moïse Azria; Robin A Fairhurst; Steven J Charlton; Brian P Rich
阅读更多 →

心血管疾病Disease-linked mutations alter the stoichiometries of HCN-KCNE2 complexes.

期刊：Scientific reports发表年份：2019作者：Yoann Lussier; Oliver Fürst; Eva Fortea; Marc Leclerc; Dimitri Priolo; Lena Moeller; Daniel G Bichet; Rikard Blunck; Nazzareno D'Avanzo
阅读更多 →

心血管疾病Vascular Protection and Decongestion Without Renin-Angiotensin-Aldosterone System Stimulation Mediated by a Novel Dual-Acting Vasopressin V1a/V2 Receptor Antagonist.

期刊：Journal of cardiovascular pharmacology发表年份：2019作者：Peter Kolkhof; Elisabeth Pook; Mira Pavkovic; Axel Kretschmer; Anja Buchmüller; Hanna Tinel; Martina Delbeck; Thomas Mondritzki; Pierre Wasnaire; Wilfried Dinh; Hubert Truebel; Jörg Hüser; Carsten Schmeck
阅读更多 →